Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes

Abstract

Objective:Survey of nicotine, tar, and carbon monoxide (CO) smoke deliveries from 77 cigarette brands purchased in 35 countries was conducted using a standardised machine smoking method. The goal of this study was to determine regional variations and differences in the tar, nicotine, and CO smoke yields of a cigarette brand manufactured by a leading transnational corporation and of non-US locally popular cigarette brands.Design:The majority of the cigarettes were purchased in each of the participating countries by delegate members of the World Health Organization and forwarded to the Centers for Disease Control and Prevention for analysis. Smoke deliveries were determined using a standardised smoking machine method and subsequent gravimetric and gas chromatography analysis.Results:The smoke deliveries varied widely. Mainstream smoke deliveries varied from 6.8 to 21.6 mg tar/cigarette, 0.5 to 1.6 mg nicotine/cigarette, and 5.9 to 17.4 mg CO/cigarette. In addition to the smoke deliveries, the cigarettes were examined to determine physical parameters such as filter composition, length, and ventilation levels.Conclusion:Analysis of the smoke deliveries suggested that cigarettes from the Eastern Mediterranean, Southeast Asia, and Western Pacific WHO regions tended to have higher tar, nicotine, and CO smoke deliveries than did brands from the European, American, or African WHO regions surveyed.

Fine particulate matter concentrations in smoking households: just how much secondhand smoke do you breathe in if you live with a smoker who smokes indoors?

“…The overall mass of PM 2.5 inhaled over an 80-year period for a person living in a typical SF home is about 0.76 g compared with a similar person living in a smoking home, who would inhale about 5.82 g. This 5 g lifetime difference represents the additional PM inhaled by a non-smoker living with a smoker and, by epidemiological data,1 is associated with clinically meaningful increases in risk for a wide variety of disease processes. Assuming an average of 14 mg of PM 2.5 inhaled per smoked cigarette,31 a non-smoker living in a smoking home inhales a similar mass of fine PM that a person would inhale if they smoked 1 cigarette every day for about 1 year of their life. It is worth noting here that a smoker with a 20 cigarette per day habit over a 62 year (18–80 years) period has a lifetime mass intake of 6.3 kg PM 2.5 .…”

Cigarette smoke and related risk factors in neurological disorders: An update

“…Literature allied to tobacco-related illnesses suggest that these diseases remain the foremost cause of avertable death, with approximately 430,000 annual deaths in the United States and roughly about 4 million annual deaths worldwide. Upto-date projections imply that tobacco use threatens 10 million lives every 12 months by 2030, especially in developing countries with 70% mortality [5,6]. A recent statistical report published in Hindustan Times revealed that 1 million people die because of cigarette smoke exposure in India every year.…”

Folding, activity and import of steroidogenic acute regulatory protein into mitochondria changed by nicotine exposure

“…5-1 . 6 mg nicotine per cigarette (Calafat et al 2004, Shihadeh & Saleh 2005, which was found to be 0 . 01 mg/ml (0 .…”